Published in Circulation on March 07, 2011
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study. Eur Heart J (2015) 1.49
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2014) 1.43
The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J (2011) 1.25
Biophysical modeling to simulate the response to multisite left ventricular stimulation using a quadripolar pacing lead. Pacing Clin Electrophysiol (2011) 0.99
Elimination of phrenic nerve stimulation occurring during CRT: follow-up in patients implanted with a novel quadripolar pacing lead. J Interv Card Electrophysiol (2011) 0.98
Haemodynamic evaluation of alternative left ventricular endocardial pacing sites in clinical non-responders to cardiac resynchronisation therapy. Neth Heart J (2016) 0.92
Phrenic nerve stimulation in cardiac resynchronization therapy. J Interv Card Electrophysiol (2014) 0.91
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J (2012) 0.90
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. J Interv Card Electrophysiol (2014) 0.88
Multimodality imaging in interventional cardiology. Nat Rev Cardiol (2012) 0.87
Method to create regional mechanical dyssynchrony maps from short-axis cine steady-state free-precession images. J Magn Reson Imaging (2013) 0.85
Postprocedure mapping of cardiac resynchronization lead position using standard fluoroscopy systems: implications for the nonresponder with scar. Pacing Clin Electrophysiol (2014) 0.84
Devices in the management of advanced, chronic heart failure. Nat Rev Cardiol (2012) 0.83
Three-dimensional electroanatomic mapping of the coronary veins during cardiac resynchronization therapy implant: feasibility and possible applications. J Interv Card Electrophysiol (2014) 0.83
The relative role of patient physiology and device optimisation in cardiac resynchronisation therapy: A computational modelling study. J Mol Cell Cardiol (2015) 0.82
Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial. PLoS One (2013) 0.82
Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible. J Interv Card Electrophysiol (2015) 0.81
Standard chest radiograph predicts left ventricular lead location in chronic resynchronization therapy patients more accurately than intraoperative fluoroscopy. J Interv Card Electrophysiol (2012) 0.81
Cardiac resynchronization therapy: history, present status, and future directions. Ochsner J (2014) 0.81
Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming. World J Cardiol (2014) 0.79
How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning. Heart Fail Rev (2012) 0.79
Limitations of chronic delivery of multi-vein left ventricular stimulation for cardiac resynchronization therapy. J Interv Card Electrophysiol (2015) 0.78
Short-Term Availability of Viable Left Ventricular Pacing Sites with Quartet™ Quadripolar Leads. Med Sci Monit (2017) 0.78
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead. J Interv Card Electrophysiol (2013) 0.77
Developments in Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev (2015) 0.77
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol (2016) 0.76
Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure. Open Heart (2015) 0.75
ICE Guided CRT: Is there Evidence of Reverse Remodeling? J Atr Fibrillation (2016) 0.75
High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant. J Cardiovasc Electrophysiol (2014) 0.75
Analysis of lead placement optimization metrics in cardiac resynchronization therapy with computational modelling. Europace (2016) 0.75
Scar burden assessed by Selvester QRS score predicts prognosis, not CRT clinical benefit in preventing heart failure event and death: A MADIT-CRT sub-study. J Electrocardiol (2016) 0.75
Device therapy: avoid apical lead position in CRT. Nat Rev Cardiol (2011) 0.75
Almanac 2011: Cardiac Arrhythmias and Pacing. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
Strain-time curve analysis by speckle tracking echocardiography in cardiac resynchronization therapy: Insight into the pathophysiology of responders vs. non-responders. Cardiovasc Ultrasound (2016) 0.75
Attitudes of Implanting Physicians about Cardiac Rhythm Management Devices and Their Features. ISRN Cardiol (2013) 0.75
The postimplantation electrocardiogram predicts clinical response to cardiac resynchronization therapy. Pacing Clin Electrophysiol (2015) 0.75
HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011. Heart Rhythm (2011) 0.75
Current Evidence and Recommendations for Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev (2014) 0.75
Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD. PLoS One (2017) 0.75
Pre-Implant Assessment For Optimal LV Lead Placement In CRT: ECG, ECHO, or MRI? J Atr Fibrillation (2015) 0.75
Predictors of mortality, LVAD implant, or heart transplant in primary prevention cardiac resynchronization therapy recipients: The HF-CRT score. Heart Rhythm (2015) 0.75
Device therapies: new indications and future directions. Curr Cardiol Rev (2015) 0.75
Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression. J Korean Med Sci (2014) 0.75
What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population. J Interv Card Electrophysiol (2016) 0.75
Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference. J Interv Card Electrophysiol (2017) 0.75
A novel fluoroscopic method of measuring right-to-left interlead distance as a predictor of reverse left ventricular remodeling after cardiac resynchronization therapy. J Interv Card Electrophysiol (2013) 0.75
Left ventricular or biventricular pacing? Single or multielectrode leads? An implanter's viewpoint. J Interv Card Electrophysiol (2014) 0.75
Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy. J Arrhythm (2017) 0.75
Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol (2016) 0.75
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol (2002) 5.74
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation (2004) 4.56
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Long QT syndrome. J Am Coll Cardiol (2008) 4.08
Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med (2014) 3.80
Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation (2004) 3.78
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol (2008) 3.73
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J (2004) 3.15
Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol (2003) 3.05
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation (2004) 3.03
Long QT syndrome in adults. J Am Coll Cardiol (2007) 2.93
Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation (2007) 2.88
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm (2009) 2.82
Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest (2006) 2.69
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol (2013) 2.68
Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol (2009) 2.65
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol (2004) 2.63
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation (2004) 2.63
Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol (2005) 2.62
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.56
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation (2006) 2.52
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med (2013) 2.44
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med (2005) 2.40
Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation (2008) 2.40
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol (2008) 2.39
Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol (2006) 2.32
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol (2012) 2.31
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol (2008) 2.31
Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol (2012) 2.26
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol (2003) 2.22
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation (2002) 2.20
A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace (2013) 2.19
Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol (2002) 2.19